SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (376)6/30/1997 9:09:00 PM
From: Bill Wexler   of 1728
 
So why not pay $10 billion for the company right now?

I think there is some future for Genomics; however, I think it is way too early to start placing such large bets. Like I said before, I like Dr. Zaffaroni and I'm interested in the technology, but not at this price. By the way, Zaffaroni's companies haven't done such a spectacular job of returning value to their shareholders. Buying AZA stock 10 years ago would have got you nowhere compared to investing in Bonds or an index fund. I also want to see how the curretn management team at Affymetrix pans out. So far I'm not encouraged by the large numbers of 144 filings.

From my experience, story stocks like this have a tendency to get hammered when they reach these lofty levels. Affymetrix - no matter how much I may like the story - is still a development stage company. As such, the chances are well over 90% that the company will never turn a profit.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext